BioFusion Journal of Biomaterials and Tissue Engineering

Editorial Panel View Editorial Board

About the Journal

BioFusion: Journal of Biomaterials and Tissue Engineering is an open-access, peer-reviewed journal that is committed to publishing high-quality research at the intersection of biomaterials science and tissue engineering. This journal provides a unique platform for disseminating innovative research that focuses on the development and application of biomaterials in the medical field, particularly in the areas of tissue regeneration, implant technology, and personalized medicine.

The journal covers the rapidly advancing field of biomaterials, which are integral to the creation of medical devices, implants, prosthetics, and tissue engineering strategies. These materials have revolutionized the medical landscape, offering solutions to pressing challenges in healthcare, such as organ failure, tissue injury, and chronic diseases. BioFusion serves as a forum for presenting research that explores new biomaterials with enhanced properties, as well as innovative methods for incorporating these materials into clinical applications. From the design and synthesis of biomaterials to their in vivo applications, the journal seeks to highlight work that addresses the need for safer, more effective, and sustainable solutions for patient care.

As the field of tissue engineering continues to grow, BioFusion publishes research that contributes to the development of functional tissues, advanced drug delivery systems, and implantable devices. The journal aims to facilitate the transition of laboratory findings into clinical applications by publishing both fundamental studies and applied research that investigates how biomaterials interact with cells and tissues. This includes examining the role of biomaterials in tissue repair and regeneration, the use of scaffolds in supporting tissue growth, and the integration of biomaterials with medical devices to improve patient outcomes.

In addition to material innovation, the journal places strong emphasis on the ethical and regulatory aspects of biomaterials research, as well as the safety and biocompatibility of new materials. BioFusion welcomes contributions that address these critical areas, ensuring that the work published in the journal not only advances scientific understanding but also aligns with clinical needs and standards.

By publishing high-quality, peer-reviewed research, BioFusion contributes to the continued progress of biomaterials and tissue engineering. The journal serves as a bridge between laboratory research and clinical practice, encouraging collaboration among material scientists, biomedical engineers, clinicians, and regulatory experts to drive forward the translation of research into real-world healthcare solutions.

All content in BioFusion is published under an open-access model, ensuring that research is freely accessible to the global scientific community. This enables the rapid exchange of knowledge and fosters innovation across disciplines, helping to accelerate the development of novel materials and techniques that will shape the future of healthcare. The journal’s commitment to scientific excellence and global accessibility makes it an essential resource for researchers and professionals in the fields of biomaterials, tissue engineering, and regenerative medicine.